Clinical trials on venom immunotherapy

Clinical trials on venom immunotherapy evaluate a treatment aimed at desensitizing individuals allergic to insect stings, like bees or wasps. In these trials, patients receive gradually increasing doses of venom over time, helping their immune system build tolerance. Researchers monitor safety, effectiveness, and any side effects. The goal is to reduce the severity of allergic reactions or even prevent them entirely. Successful trials may lead to improved therapies that enhance the quality of life for those allergic to insect venom, offering a potential long-term solution to a serious health risk.